Understanding New Recommendations for Respiratory Syncytial Virus Prevention in Pregnancy

• 2024

  Log in to bookmark this resource.

  Log in
• Brenna Hughes; Rebecca Horgan; Jerri Waller; Yara Hage Diab; George Saade
PMID: 38330405DOI: https://dx.doi.org/10.1097/AOG.0000000000005524

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article explains new guidelines for preventing respiratory syncytial virus (RSV) in pregnant women. RSV is a major cause of illness in infants. Previously, prevention focused on giving antibodies to high-risk newborns and encouraging breastfeeding. Now, health experts recommend all newborns receive antibodies during RSV season. A new vaccine for pregnant women has been approved to protect babies from RSV if they are not planning other antibody treatments like nirsevimab for their infants. The article reviews the evidence and future considerations for using this vaccine during pregnancy to help keep babies safe from RSV-related illnesses.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antibodies, Monoclonal; Immunization; Immunization, Passive; Infant; Infant, Newborn; Pregnancy; Pregnant Women; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Vaccination

Institutions: Duke University

---

More like this

Nirsevimab: Alleviating the Burden Of RSV Morbidity in Young Children 2024 · Duke-NUS Medical School, KK Women's & Children's Hospital, University of New South Wales, Macquarie University, National Centre for Immunisation Research and Surveillance (NCIRS) CDC Changes Recommendations Due to Severe Nirsevimab Shortage During the 2023-2024 RSV Season 2024 · Dow University of Health Sciences, D.G Khan Medical College, Kabul University of Medical and Sciences Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants 2023 · St. George's University Hospitals NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust, Liverpool University Hospitals Foundation NHS Trust, Sanofi, Université Paris-Saclay, Assistance Publique - Hôpitaux de Paris (AP-HP)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---